Tecogen (TGEN) General Counsel IV Buys 19,342 Shares
TGEN's General Counsel, Whiting John Kimball IV, recently bought 19,342 shares.
Reviewed by automated data checks against the source filing. How we make and check alerts
Whiting John Kimball IV, General Counsel & Secretary at Tecogen Inc. ($TGEN), bought 19,342 shares on June 26, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $TGEN is down 15.7% after 1 week, down 35.4% after 1 month and down 59.6% to date (from the $5.17 close on Jun 26, 2026).
TGEN
Tecogen Inc.
Key Points
- Whiting John Kimball IV, TGEN's General Counsel, acquired 19,342 shares on June 26, 2026.
- Shares of TGEN traded at $5.22 on Wednesday, with several institutional investors adjusting their positions.
- Analysts from Roth Capital and H.C. Wainwright maintain buy ratings, with targets of $15.00 and $4.50 respectively.
Get $TGEN trade alerts by text
We text you when insiders, Congress or big funds trade $TGEN. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Tecogen Inc. alert may contain errors. Disclosures
Whiting John Kimball IV, General Counsel & Secretary at TGEN, bought 19,342 shares on June 26, 2026. This insider transaction was not part of a pre-planned trading program, indicating personal decision-making in the purchase.
Other Institutional Activity in TGEN
Vanguard Capital Management LLC opened a new position in TGEN, acquiring 769,964 shares valued at approximately $1.97 million. Bard Associates Inc slightly reduced its stake by 798 shares, now holding 688,309 shares worth about $1.76 million, reflecting a 0.1% decrease. Clear Harbor Asset Management, LLC increased its holdings by 40,000 shares to a total of 650,000 shares, valued at $1.66 million, a 6.6% increase. Portolan Capital Management, LLC trimmed its position by 2,255 shares, holding 443,555 shares worth about $1.14 million, marking a 0.5% decrease.
Tecogen Inc. Stock Up 67.3%
Shares of TGEN traded near $5.22 on Wednesday. The stock has seen a 52-week range from a low of $3.50 to a high of $7.80. Its 50-day moving average is $5.10, and the 200-day moving average is $5.30, indicating some stability in recent months.
Insider Buying and Selling at Tecogen Inc.
On June 26, 2026, several insiders at TGEN made purchases. Angelina Galiteva bought 25,000 shares at $5.17 each. CEO Abinand Rangesh acquired a total of 200,122 shares, with 26,041 shares at $5.17 and the rest unspecified in price. Roger Deschenes, CAO, and Stephen Lafaille, VP of Business Development, each bought 29,013 shares. COO and President Robert Panora purchased 9,671 shares.
Analysts Set New Price Targets
On August 18, 2025, Roth Capital initiated coverage of TGEN with a 'buy' rating and a price target of $15.00. H.C. Wainwright reiterated its 'buy' rating on March 17, 2023, with a price target of $4.50. The consensus among analysts suggests a positive outlook for TGEN.
Bottom Line
Insider buying activity at TGEN, particularly by General Counsel Whiting John Kimball IV, signals confidence in the company's prospects. Institutional investors have adjusted their holdings, with some increasing their stakes. Analysts maintain positive ratings, suggesting potential growth. Remember, insider transactions and institutional filings are often backward-looking and may not reflect current positions.
Related Filing Alerts
Source: Whiting John Kimball IV's Form 4 filing on $TGEN (Jun 26, 2026). Find the original filing: TGEN Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts